NEW YORK (GenomeWeb) – PerkinElmer after the close of the market on Thursday reported a 1 percent dip year over year in its first quarter revenues, though on a constant-currency basis it had revenue growth of 5 percent.

For the three months ended March 29, 2015, PerkinElmer's revenues decreased to $526.9 million from $530.6 million in the prior-year period. Adjusted revenues for the quarter were $527.2 million compared to $532.1 million for Q1 2014, as the firm fell short of the average Wall Street estimate for revenues of $537.9 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.